202 related articles for article (PubMed ID: 19201549)
1. Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas.
Shinohara ET; Mitra N; Guo M; Metz JM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1191-8. PubMed ID: 19201549
[TBL] [Abstract][Full Text] [Related]
2. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.
Vern-Gross TZ; Shivnani AT; Chen K; Lee CM; Tward JD; MacDonald OK; Crane CH; Talamonti MS; Munoz LL; Small W
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):189-98. PubMed ID: 20971573
[TBL] [Abstract][Full Text] [Related]
3. Brachytherapy in the treatment of cholangiocarcinoma.
Shinohara ET; Guo M; Mitra N; Metz JM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):722-8. PubMed ID: 20207503
[TBL] [Abstract][Full Text] [Related]
4. External-beam radiotherapy for localized extrahepatic cholangiocarcinoma.
Ben-David MA; Griffith KA; Abu-Isa E; Lawrence TS; Knol J; Zalupski M; Ben-Josef E
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):772-9. PubMed ID: 17011452
[TBL] [Abstract][Full Text] [Related]
5. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage.
Kao J; Lavaf A; Teng MS; Huang D; Genden EM
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):362-70. PubMed ID: 18164833
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
Stessin AM; Meyer JE; Sherr DL
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
[TBL] [Abstract][Full Text] [Related]
9. Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.
Kaiser GM; Frühauf NR; Lang H; Sauerwein W; Sotiropoulos GC; Zöpf T; Grabellus F; Wittig A; Oldhafer KJ; Malagó M; Broelsch CE
Hepatogastroenterology; 2008; 55(88):1951-4. PubMed ID: 19260456
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study.
Shaib YH; Davila JA; Henderson L; McGlynn KA; El-Serag HB
J Clin Gastroenterol; 2007; 41(10):911-7. PubMed ID: 18090160
[TBL] [Abstract][Full Text] [Related]
11. Cholangiocarcinoma: clinical significance of tumor location along the extrahepatic bile duct.
Alden ME; Waterman FM; Topham AK; Barbot DJ; Shapiro MJ; Mohiuddin M
Radiology; 1995 Nov; 197(2):511-6. PubMed ID: 7480704
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of surgical approach for extrahepatic cholangiocarcinoma.
Shi QF; Liang TB; Qin YS; Wang WL; Shen Y; Zhang M; Zheng SS
Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):622-6. PubMed ID: 18086629
[TBL] [Abstract][Full Text] [Related]
13. [Long-term results of 84 surgically treated patients with extrahepatic bile duct carcinoma].
Zheng SS; Qin YS; Liang TB; Huang DS; Zhang M; Wang WL; Shen Y; Wang JH
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):554-6. PubMed ID: 16438856
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for prognosis of hilar cholangiocarcinoma: postresection radiotherapy improves survival.
Cheng Q; Luo X; Zhang B; Jiang X; Yi B; Wu M
Eur J Surg Oncol; 2007 Mar; 33(2):202-7. PubMed ID: 17088040
[TBL] [Abstract][Full Text] [Related]
15. An aggressive approach to extrahepatic cholangiocarcinomas is warranted: margin status does not impact survival after resection.
Hernandez J; Cowgill SM; Al-Saadi S; Villadolid D; Ross S; Kraemer E; Shapiro M; Mullinax J; Cooper J; Goldin S; Zervos E; Rosemurgy A
Ann Surg Oncol; 2008 Mar; 15(3):807-14. PubMed ID: 18181000
[TBL] [Abstract][Full Text] [Related]
16. Management of hilar bile duct carcinoma.
Bathe OF; Pacheco JT; Ossi PB; Hamilton KL; Franceschi D; Sleeman D; Levi JU; Livingstone AS
Hepatogastroenterology; 2001; 48(41):1289-94. PubMed ID: 11677948
[TBL] [Abstract][Full Text] [Related]
17. A single center experience with extrahepatic cholangiocarcinomas.
Johnson SR; Kelly BS; Pennington LJ; Hanto DW
Surgery; 2001 Oct; 130(4):584-90; discussion 590-2. PubMed ID: 11602888
[TBL] [Abstract][Full Text] [Related]
18. A national propensity-adjusted analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma.
McDade TP; Hill JS; Simons JP; Piperdi B; Ng SC; Zhou Z; Kadish SP; Fitzgerald TJ; Tseng JF
Cancer; 2010 Jul; 116(13):3257-66. PubMed ID: 20564625
[TBL] [Abstract][Full Text] [Related]
19. Palliative surgical bypass versus percutaneous transhepatic biliary drainage on unresectable hilar cholangiocarcinoma.
Wongkonkitsin N; Phugkhem A; Jenwitheesuk K; Saeseow OT; Bhudhisawasdi V
J Med Assoc Thai; 2006 Nov; 89(11):1890-5. PubMed ID: 17205870
[TBL] [Abstract][Full Text] [Related]
20. Hepatic portal cholangiocarcinoma: a clinical analysis of 70 cases.
Zhang HY; Kong YL; Zhang HY; He XJ; Zhang H; Liu CL; Zhao G; Xiao M; Zhang XD; Feng ZQ
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):418-21. PubMed ID: 18693179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
